Stephanie D. Schech

630 total citations
12 papers, 469 citations indexed

About

Stephanie D. Schech is a scholar working on Surgery, Infectious Diseases and General Health Professions. According to data from OpenAlex, Stephanie D. Schech has authored 12 papers receiving a total of 469 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Surgery, 2 papers in Infectious Diseases and 2 papers in General Health Professions. Recurrent topics in Stephanie D. Schech's work include Lipoproteins and Cardiovascular Health (3 papers), Muscle and Compartmental Disorders (2 papers) and Hepatitis B Virus Studies (2 papers). Stephanie D. Schech is often cited by papers focused on Lipoproteins and Cardiovascular Health (3 papers), Muscle and Compartmental Disorders (2 papers) and Hepatitis B Virus Studies (2 papers). Stephanie D. Schech collaborates with scholars based in United States. Stephanie D. Schech's co-authors include Deborah Shatin, Richard Platt, K. Arnold Chan, Susan E. Andrade, Michael J. Goodman, Jerry H. Gurwitz, Wayne A. Ray, Diane K. Wysowski, Walter Smalley and David J. Graham and has published in prestigious journals such as JAMA, Journal of Clinical Epidemiology and The Journal of Pediatrics.

In The Last Decade

Stephanie D. Schech

11 papers receiving 449 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephanie D. Schech United States 8 140 99 86 63 62 12 469
Miguel Gil Spain 13 130 0.9× 40 0.4× 168 2.0× 61 1.0× 49 0.8× 37 643
Stephen Kogut United States 15 58 0.4× 101 1.0× 93 1.1× 96 1.5× 36 0.6× 67 729
Andreea Farcaș Romania 11 48 0.3× 80 0.8× 51 0.6× 84 1.3× 87 1.4× 41 549
Torbjörn Callréus Denmark 14 54 0.4× 132 1.3× 100 1.2× 46 0.7× 54 0.9× 30 826
Sze Ling Chan Singapore 13 124 0.9× 29 0.3× 31 0.4× 66 1.0× 50 0.8× 58 474
Mònica Sabaté Spain 13 42 0.3× 26 0.3× 37 0.4× 53 0.8× 27 0.4× 37 406
Sabin S Egger Switzerland 8 47 0.3× 69 0.7× 77 0.9× 89 1.4× 64 1.0× 13 463
Marion Lepelley France 16 66 0.5× 42 0.4× 61 0.7× 55 0.9× 141 2.3× 42 574
Hélène Théophile France 15 71 0.5× 39 0.4× 79 0.9× 93 1.5× 228 3.7× 28 602
Audrey J. Lee United States 12 84 0.6× 43 0.4× 39 0.5× 60 1.0× 16 0.3× 21 496

Countries citing papers authored by Stephanie D. Schech

Since Specialization
Citations

This map shows the geographic impact of Stephanie D. Schech's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephanie D. Schech with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephanie D. Schech more than expected).

Fields of papers citing papers by Stephanie D. Schech

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephanie D. Schech. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephanie D. Schech. The network helps show where Stephanie D. Schech may publish in the future.

Co-authorship network of co-authors of Stephanie D. Schech

This figure shows the co-authorship network connecting the top 25 collaborators of Stephanie D. Schech. A scholar is included among the top collaborators of Stephanie D. Schech based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephanie D. Schech. Stephanie D. Schech is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Meropol, Sharon B., K. Arnold Chan, Zhen Chen, et al.. (2008). Adverse events associated with prolonged antibiotic use. Pharmacoepidemiology and Drug Safety. 17(5). 523–532. 50 indexed citations
2.
Brinker, Allen, Andrew D. Mosholder, Stephanie D. Schech, Margaret Burgess, & Mark Avigan. (2007). Indication and Use of Drug Products Used to Treat Attention-Deficit/Hyperactivity Disorder: A Cross-Sectional Study with Inference on the Likelihood of Treatment in Adulthood. Journal of Child and Adolescent Psychopharmacology. 17(3). 328–333. 8 indexed citations
3.
Brinker, Allen, Stephanie D. Schech, Margaret Burgess, & Mark Avigan. (2007). An Observational Study of Cholecystectomy in Patients Receiving Tegaserod. Drug Safety. 30(7). 581–588. 2 indexed citations
4.
Chang, Soju, Elizabeth Begier, Stephanie D. Schech, et al.. (2007). Perinatal Hepatitis B Transmission and Vaccination Timing in a Managed Care Cohort. The Pediatric Infectious Disease Journal. 26(4). 329–333. 2 indexed citations
5.
Schech, Stephanie D., David J. Graham, Judy A. Staffa, et al.. (2006). Risk factors for statin‐associated rhabdomyolysis. Pharmacoepidemiology and Drug Safety. 16(3). 352–358. 96 indexed citations
6.
Schech, Stephanie D., Allen Brinker, Deborah Shatin, & Margaret Burgess. (2006). New‐onset and idiopathic thrombotic thrombocytopenic purpura: Incidence, diagnostic validity, and potential risk factors. American Journal of Hematology. 81(9). 657–663. 5 indexed citations
7.
Freed, Gary L., et al.. (2005). Changes in the proportion and volume of care provided to children by generalists and subspecialists. The Journal of Pediatrics. 146(1). 14–19. 20 indexed citations
8.
Andrade, Susan E., David J. Graham, Judy A. Staffa, et al.. (2005). Health plan administrative databases can efficiently identify serious myopathy and rhabdomyolysis. Journal of Clinical Epidemiology. 58(2). 171–174. 39 indexed citations
9.
Graham, David J., Judy A. Staffa, Lois La Grenade, et al.. (2005). Rhabdomyolysis and Lipid-Lowering Drugs—Reply. JAMA. 293(12). 1448–1448.
10.
Shatin, Deborah, Stephanie D. Schech, Keyur Patel, & John G. McHutchison. (2004). Population-based hepatitis C surveillance and treatment in a national managed care organization.. PubMed. 10(4). 250–6. 43 indexed citations
11.
Yokoe, Deborah S., Rachel S. Dokholyan, Michael C. Iannuzzi, et al.. (2004). Pharmacy Data for Tuberculosis Surveillance and Assessment of Patient Management. Emerging infectious diseases. 10(8). 1426–1431. 13 indexed citations
12.
Smalley, Walter, Deborah Shatin, Diane K. Wysowski, et al.. (2000). Contraindicated Use of Cisapride. JAMA. 284(23). 3036–3036. 191 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Miguel Gil Breakdown of academic impact, for papers by Stephen Kogut Breakdown of academic impact, for papers by Andreea Farcaș Breakdown of academic impact, for papers by Torbjörn Callréus Breakdown of academic impact, for papers by Sze Ling Chan Breakdown of academic impact, for papers by Mònica Sabaté Breakdown of academic impact, for papers by Sabin S Egger Breakdown of academic impact, for papers by Marion Lepelley Breakdown of academic impact, for papers by Hélène Théophile Breakdown of academic impact, for papers by Audrey J. Lee
Rankless by CCL
2026